ArticleScience China. Life sciences2018

A novel human mAb (MERS-GD27) provides prophylactic and postexposure efficacy in MERS-CoV susceptible mice.

Peihua Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.